Skip to content

Clinical trials

Phase 3 Amyotrophic Lateral Sclerosis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyotrophic Lateral Sclerosis Phase: Phase 3 Country / region: France Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20111
20123
20151
20162
20182
20193
20202
20215
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated8
Recruiting2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris3
Cytokinetics3
Amylyx Pharmaceuticals Inc.2
Humanitas Mirasole SpA2
Knopp Biosciences2
Orion Corporation, Orion Pharma2
ZevraDenmark2
AB Science1
Alector Inc.1
Alexion Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyotrophic Lateral Sclerosis24
Motor Neuron Disease4
Frontotemporal Dementia1
Muscular Dystrophy, Duchenne1
Myotonia Congenita1
Neurodegenerative Diseases1
Neuromuscular Diseases1
Respiratory Insufficiency1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.